January 2019 Funding Opportunities and Announcements
Questions about this "funding flash"? Contact us at cancercenter@gwu.edu. View previous issues here. Interested in subscribing to future updates? Click the button below:
Clinical and Translational Science Institute at Children's National (CTSI-CN) Mentored Career Development Award
The Mentored Career Development Award (KL2) program recruits junior faculty early in their career who have demonstrated the aptitude and commitment to undertake multidisciplinary CTR. In this round of the KL2 process, up to 2 awards will be made if sufficiently meritorious applications are received.
Deadline: January 18, 2019 (LOI)
Amount and Project Period: Up to $100,000 per year for 2 years
Eligibility : Junior faculty of both Children's National Health System and the George Washington University are eligible to apply. All applicants for KL2 grant consideration, including the letter of intent stage, must be CTSI-CN members. Membership is free.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: Scientific Review Committee
Sarcoma Foundation of America Research Grants
The Sarcoma Foundation of America has developed a program to provide grants to investigators interested in translational science sarcoma research. Funding of up to $50,000, allowing up to 10 percent indirect costs, is available to cover equipment and supplies in support of research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas. In accordance with the mission of the Foundation, research involving the development of novel agents against sarcoma, or research that could potentially lead to the development of novel agents against sarcoma, is eligible for this funding.
Deadline: January 31, 2019
Amount and Project Period: $50,000 over 1 year
Eligibility : SFA will only accept applications that focus on the following areas of research: Omic characterization of sarcomas and definition of novel targets, Omic patterns of sensitivity and resistance to existing agents, systematic therapy combinations, or immunotherapy.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Leukemia Research Foundation Hollis Brownstein Research Grants Program
The foundation provides one year grants of $100,000 to selected New Investigator researchers to allow innovative scientists to act on their ideas, and try new procedures and experiments that will hopefully lead to significant breakthroughs. The Leukemia Research Foundation funds the research of scientists that are from independent labs, working under the tutelage of a research mentor.
Deadline: February 1, 2019 (LOI)
Amount and Project Period: $100,000 over 1 year
Eligibility : Preference given to proposals that focus on leukemia, lymphoma, MDS, and multiple myeloma. Early career investigators are classified as those investigators within seven (7) years of their first independent position as of July 1, 2020.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: Independent Medical Advisory Board chaired by Dr. Patrick Stiff, Director of the Cardinal Bernardin Cancer Center, Loyola University Medical Center
Hemostasis and Thrombosis Research Society/Novo Nordisk Clinical Fellowship Awards in Hemophilia and Rare Blood Disorders
Grant provides financial support for early career physicians interested in enhancing their training in hematology with a 12-month fellowship focused on hemophilia and RBDs under the guidance of an experienced mentor.
Deadline: February 1, 2019
Amount and Project Period: $119,600 over 1 year
Eligibility : Applicants may be up to 3 years post-fellowship as of July 1, 2019
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: Scientific Review Committee
Aplastic Anemia and MDS International Foundation Research Grants
Grants support researchers dedicated to the study of bone marrow disorders to advance the understanding, prevention and treatment of the following bone marrow disorders: Aplastic Anemia, Myelodysplastic Sydromes and MDS transition to Acute Myeloid Leukemia, Overlap between MDS and Myeloproliferative Neoplasms including Chronic Myelomonocytic Leukemia, Paroxysmal Nocturnal Hemoglobinuria, and Pure Red Cell Aplasia. The Foundation is interested in funding research across the spectrum of basic and clinical science, but highest priority is for studies that have the potential to impact prevention, diagnosis, risk-stratification, or treatment of these diseases within three years.
Deadline: February 15, 2019 (LOI)
Amount and Project Period: $60,000 over 2 years
Eligibility : Open to investigators at all levels
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: An NIH-model peer-review process is used to evaluate applications. Reviewers include members of the AAMDSIF Scientific Medical Advisory Board as well as ad hoc reviewers.
ASTRO Minority Summer Fellowship Award
The ASTRO Minority Summer Fellowship Award introduces medical students from backgrounds that are under-represented in medicine to the discipline of radiation oncology early in their medical education. Medical students in all years are encouraged to apply; preference will be given to first- and second-year students. In an effort to promote radiation oncology as a career choice, the fellowship will provide medical students with an experience designed to expose students to clinical, basic and translational research questions in radiation oncology. Members of ASTRO's Committee on Health Equity, Diversity and Inclusion are assigned as liaisons to past and present Minority Summer Fellowship awardees to check in periodically throughout the year, gain feedback on the fellowship experience and help provide a mentorship opportunity as awardees advance in their training and enter into radiation oncology.
Deadline: February 15, 2019
Amount and Project Period: $4,500
Eligibility : Student must be from a background that is under-represented in medicine.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: Committee on Health Equity, Diversity and Inclusion Working Group
American Cancer Society Institutional Research Grants
Awarded to institutions as block grants to provide seed money for newly independent investigators to initiate research projects. These grants are renewable.
Deadline: April 1, 2019
Amount and Project Period: $360,000 over 3 years
Eligibility : N/A
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: The Society's Scientific Program Directors distribute the applications to the most appropriate Peer Review Committee and then assign each application to at least two committee members for independent and confidential review. Each committee generally has between 15 and 25 members who are leaders in their areas of expertise, plus up to three "stakeholders." A stakeholder is an individual usually without formal training as a scientist or health professional who has a strong personal interest in advancing the effort to control and prevent cancer through research and training. This interest could stem from a personal experience with the disease, such as survivorship, a family cancer experience, or being a caregiver. Depending on the grant applied for (see specific sections), the committees evaluate applications based on some or all of the following criteria: (a) the scientific merit, originality, and feasibility of the application; (b) the qualifications, experience and productivity of the applicant, and the members of the investigative team; (c) the facilities and resources available; and (d) the promise of the research or training as related to the control of cancer or to the benefit to be gained by persons with cancer.
American Cancer Society: The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services
Research to be funded by this RFA should focus on the changes in national, state, and/or local policy and the response to these changes by health care systems, insurers, payers, communities, practices, and patients. The foundation is keenly interested in supporting rapid learning research to study the effects of health policy changes on patients, providers, and health systems. This includes but is not limited to: Facilitators and barriers to care; unintended consequences; differential experiences and outcomes of patients seeking or receiving care; best practice models for quality care; and economic impact.
Deadline: April 1, 2019
Amount and Project Period: Up to $1.2M over 5 years
Eligibility : Independent investigators at all stages of their career are eligible to apply. The usual ACS restriction to investigators within the first six years of their initial independent research appointment for the Research Scholar Grant applications does not apply to this RFA.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: The Society's Scientific Program Directors distribute the applications to the most appropriate Peer Review Committee and then assign each application to at least two committee members for independent and confidential review. Each committee generally has between 15 and 25 members who are leaders in their areas of expertise, plus up to three "stakeholders." A stakeholder is an individual usually without formal training as a scientist or health professional who has a strong personal interest in advancing the effort to control and prevent cancer through research and training. This interest could stem from a personal experience with the disease, such as survivorship, a family cancer experience, or being a caregiver. Depending on the grant applied for (see specific sections), the committees evaluate applications based on some or all of the following criteria: (a) the scientific merit, originality, and feasibility of the application; (b) the qualifications, experience and productivity of the applicant, and the members of the investigative team; (c) the facilities and resources available; and (d) the promise of the research or training as related to the control of cancer or to the benefit to be gained by persons with cancer.
American Cancer Society Research Scholar Grants
The Research Scholar Grant (RSG) supports investigator-initiated projects across the cancer research continuum.
Deadline: April 1, 2019
Amount and Project Period: $792,000 over 4 years
Eligibility : Independent investigators in the first 6 years of an independent research career or faculty appointment are eligible to apply. Eligibility is extended for 8 years for clinician scientists who remain active in clinical care. RSG applicants to ONLY the Cancer Control and Prevention Research Program may be at any career stage provided that the focus of their project is either: (1) health policy/health services research or (2) achieving cancer health equity.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: The Society's Scientific Program Directors distribute the applications to the most appropriate Peer Review Committee and then assign each application to at least two committee members for independent and confidential review. Each committee generally has between 15 and 25 members who are leaders in their areas of expertise, plus up to three "stakeholders." A stakeholder is an individual usually without formal training as a scientist or health professional who has a strong personal interest in advancing the effort to control and prevent cancer through research and training. This interest could stem from a personal experience with the disease, such as survivorship, a family cancer experience, or being a caregiver. Depending on the grant applied for (see specific sections), the committees evaluate applications based on some or all of the following criteria: (a) the scientific merit, originality, and feasibility of the application; (b) the qualifications, experience and productivity of the applicant, and the members of the investigative team; (c) the facilities and resources available; and (d) the promise of the research or training as related to the control of cancer or to the benefit to be gained by persons with cancer.
American Cancer Society Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families
Pilot data are typically needed before funding agencies (e.g., NIH, VA, or the American Cancer Society) will consider funding a research project. In an effort to support clinician investigators conducting patient-oriented research in palliative care, the American Cancer Society (ACS), in parallel with the National Palliative Care Research Center (NPCRC), is soliciting applications for pilot/exploratory research grants in palliative care for cancer patients and their families. These grants will generate the pilot data necessary to maximize an investigator's chances of successfully competing for larger grants.
Deadline: April 1, 2019
Amount and Project Period: $144,000 over 2 years
Eligibility : Applicants must hold a doctorate degree (MD, PhD or equivalent) and have a full-time faculty position or equivalent at a college, university, medical school, or other fiscally responsible not-for-profit organization within the United States. Independent investigators at all stages of their career are eligible to apply. Thus, the usual ACS restriction to investigators within the first 6 years of their initial independent research appointment does not apply to this RFA.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: The Society's Scientific Program Directors distribute the applications to the most appropriate Peer Review Committee and then assign each application to at least two committee members for independent and confidential review. Each committee generally has between 15 and 25 members who are leaders in their areas of expertise, plus up to three "stakeholders." A stakeholder is an individual usually without formal training as a scientist or health professional who has a strong personal interest in advancing the effort to control and prevent cancer through research and training. This interest could stem from a personal experience with the disease, such as survivorship, a family cancer experience, or being a caregiver. Depending on the grant applied for (see specific sections), the committees evaluate applications based on some or all of the following criteria: (a) the scientific merit, originality, and feasibility of the application; (b) the qualifications, experience and productivity of the applicant, and the members of the investigative team; (c) the facilities and resources available; and (d) the promise of the research or training as related to the control of cancer or to the benefit to be gained by persons with cancer.